Innovative Gene Therapy Technique Reactivates Inactive Genes Using DNA Editing
A new gene therapy approach using CRISPR-Cas9 reactivates dormant genes by bringing them closer to genetic switches, offering hope for treating blood disorders like sickle cell disease and beta-thalassemia.
Scientists have developed a groundbreaking approach to gene therapy that involves reactivating dormant genes by manipulating their proximity to genetic switches known as enhancers. This novel method, named "delete-to-recruit," utilizes CRISPR-Cas9 technology to precisely cut out a segment of DNA between an enhancer and a gene, bringing them closer and restoring gene activity.
This advancement opens new avenues for treating genetic disorders, particularly those caused by faulty genes. The research team, comprising experts from the Hubrecht Institute, Erasmus MC, and Sanquin, demonstrated the technique's potential for conditions like sickle cell disease and beta-thalassemia, blood disorders resulting from defective hemoglobin genes. By reactivating the fetal globin gene, which is naturally active before birth but silenced afterward, the method offers a promising alternative to traditional gene therapies.
In sickle cell disease and thalassemia, reactivating fetal globin can compensate for the malfunctioning adult globin, potentially alleviating symptoms such as anemia and fatigue while reducing the need for blood transfusions. The strategy has been tested successfully in blood stem cells from healthy donors and patients, showing the ability to produce healthy red blood cells.
This technique's versatility extends beyond blood disorders, as it could be adapted to other diseases where boosting the expression of beneficial but inactive genes is therapeutic. Unlike current gene therapies, which often involve expensive and irreversible genetic modifications, delete-to-recruit offers a more targeted and potentially safer approach.
Published in the Blood Journal, this research lays the groundwork for future gene therapies that harness DNA's spatial configuration, providing new hope for patients with genetic conditions. As the field of gene therapy evolves, this innovative approach could serve as a flexible and cost-effective alternative to existing treatments.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Hunger and Neural Circuits Delay Puberty Onset in Mice
Neuroscientists at RIKEN have identified neural pathways linking hunger to delayed puberty in female mice, unveiling potential mechanisms shared with humans that connect nutrition and reproductive development.
Michigan Reports Second Measles Outbreak Amid Rising National Cases
Michigan reports its second measles outbreak of 2025 as the US reaches over 1,200 cases nationwide. The resurgence highlights the importance of vaccination to prevent severe complications and curb outbreaks.
Innovative Approaches Reveal Breast Cancer Growth Rates and Impact of Surgical Delays on Cancer Staging
New research uncovers how breast cancers grow and how surgical delays influence cancer staging, providing reassurance and guidance for patients and physicians alike.
Microplastics Bound to Proteins May Damage Brain Cells and Pose Neurotoxic Risks
New research reveals that microplastics bound to proteins can disrupt brain cell functions and pose serious neurotoxic risks, highlighting the importance of addressing plastic pollution.